IP Library Granted Patent US 12,180,247
Granted Patent B2
US 12,180,247 · App. 18/106,073 · Granted Dec 31, 2024

Oxysterols and methods of use thereof

Inventors: Francesco G. Salituro (Marlborough, MA); Albert Jean Robichaud (Boston, MA); Gabriel Martinez Botella (Wayland, MA); Boyd L. Harrison (Princeton Junction, NJ); Andrew Griffin (L'ile Bizard, CA)
Assignee: Sage Therapeutics, Inc.
C07J43/003C07J9/00C07J9/005C07J17/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,180,247
App. No.
18/106,073
Granted
Dec 31, 2024
Kind
B2
Abstract

Compounds are provided according to Formula (A): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R G are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

Claims (12)

1. A compound selected from the group consisting of:

2. A pharmaceutical composition comprising a compound of claim 1 , and a pharmaceutically acceptable carrier.

3. The compound of claim 1 , wherein the compound is selected from the group consisting of:

4. The compound of claim 1 , wherein the compound is selected from the group consisting of:

5. A pharmaceutically acceptable salt of a compound selected from the group consisting of:

6. The pharmaceutically acceptable salt of claim 5 , wherein the compound is selected from the group consisting of:

7. The pharmaceutically acceptable salt of claim 5 , wherein the compound is selected from the group consisting of:

8. A pharmaceutical composition comprising a compound of claim 3 , and a pharmaceutically acceptable carrier.

9. A pharmaceutical composition comprising a compound of claim 4 , and a pharmaceutically acceptable carrier.

10. A pharmaceutical composition comprising a pharmaceutically acceptable salt of claim 5 , and a pharmaceutically acceptable carrier.

11. A pharmaceutical composition comprising a pharmaceutically acceptable salt of claim 6 , and a pharmaceutically acceptable carrier.

12. A pharmaceutical composition comprising a pharmaceutically acceptable salt of claim 7 , and a pharmaceutically acceptable carrier.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2024
From: SALITURO, FRANCESCO G.; ROBICHAUD, ALBERT J.; MARTINEZ BOTELLA, GABRIEL; HARRISON, BOYD L.; GRIFFIN, ANDREW; LA, DANIEL
To: SAGE THERAPEUTICS, INC.
Reel/Frame 067857/0236 →
Continuity (5)
Continuation 17386364 · Jul 27, 2021
Continuation 16343238
Provisional Application 62409756 · Oct 18, 2016
Provisional Application 62409768 · Oct 18, 2016
Related Publication 20230331768A1 · Oct 19, 2023
Cited By (2)
US 12,448,409 US 12,540,157